Information on the NuvaxovidTM XBB.1.5 dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601)
If your enquiry is regarding the NuvaxovidTM XBB.1.5 dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601), you can find some useful information in the resource below.
Request Medical Information
Novavax is unable to provide medical advice regarding your health condition. Please consult your doctor, nurse or other healthcare provider, who is in the best position to advise you about the suitability of a particular treatment as they have access to the details of your medical history, as well as information on all medicinal products.
To ask Novavax Medical Information a question about a Novavax product please call
+352 20 33 17 08 between 09:00-17:00.
Report an Adverse Event (AE)
If you are concerned about an adverse event, it should be reported to the Ministry of Health https://sante.public.lu.
Alternatively, adverse events of serious concern in association with a Novavax product can be reported to Novavax Pharmacovigilance at +352 20 33 17 08 or via the Novavax Adverse Event Reporting Form.
Report a Product Quality Complaint
If you have a product quality complaint related to a physical issue with a Novavax product or its packaging, please report the complaint via ONE of the following ways:
Option 1: Complete and submit a Product Quality Complaint Form by clicking on the button below.
Option 2: Call +352 20 33 17 08 between 09:00-17:00.